1. Home
    2. »
  2. Health
    3. »
  3. Diseases

Diseases of the genitourinary system

Overactive bladder - Causes and pathogenesis

It has been reliably established that overactive bladder can be a consequence of neurogenic and non-neurogenic lesions. Neurogenic disorders occur at the level of supraspinal centers of the nervous system and the spinal cord pathways, while non-neurogenic disorders are a consequence of age-related changes in the detrusor, IVO, and anatomical changes in the position of the urethra and bladder.

Overactive bladder

Overactive bladder is a clinical syndrome that defines urgent urination with or without urgent urinary incontinence, which is usually accompanied by increased urination frequency and nocturia.

Neurogenic Bladder - Treatment

The goal of treatment for patients with neurogenic lower urinary tract dysfunction is to preserve renal function, create conditions for adequate bladder emptying or urine continence, and improve quality of life.

Neurogenic bladder - Symptoms and diagnosis

Symptoms of neurogenic lower urinary tract dysfunction are mainly represented by characteristic signs of accumulation: urgent (imperative) and frequent urination during the day and night, as well as urgent urinary incontinence. These symptoms are characteristic of neurogenic detrusor overactivity.

Neurogenic bladder

Neurogenic bladder (neurogenic lower urinary tract dysfunction includes various damages to the function of the lower urinary tract due to neurological diseases and disorders.

Brachytherapy (radiation therapy) for prostate cancer

Brachytherapy (interstitial radiotherapy) is a high-tech method that emerged at the intersection of radiotherapy and minimally invasive urology. The brachytherapy technique was described in 1983, it allowed the development of preoperative three-dimensional planning of source placement and postoperative dosimetry.

Palliative treatment for prostate cancer

Most patients with metastatic prostate cancer suffer from some degree of pain, vertebral compression fractures, pathological fractures, and spinal cord compression.

Hormone-refractory prostate cancer - Treatment

Hormone-refractory prostate cancer is a heterogeneous disease that includes several subgroups of patients with different average survival times.

Metastatic prostate cancer - Treatment

By definition, locally advanced and metastatic prostate cancer is not amenable to radical treatment. Historically, most patients were presented with this form of the disease.

Locally advanced prostate cancer - Treatment

Locally advanced prostate cancer (T3) is cancer that has spread beyond the prostate capsule with invasion of the paresis, bladder neck, seminal vesicles, but without lymph node involvement or distant metastasis.